Simultaneous Effects of a Selective EP2 Agonist, Omidenepag, and a Rho-Associated Coiled-Coil Containing Protein Kinase Inhibitor, Ripasudil, on Human Orbital Fibroblasts

Journal of Ocular Pharmacology and Therapeutics, Ahead of Print.

Source: Journal of Ocular Pharmacology and Therapeutics - June 23, 2023 Category: Opthalmology Authors: Fumihito Hikage Megumi Watanabe Tatsuya Sato Araya Umetsu Yuri Tsugeno Masato Furuhashi Hiroshi Ohguro Source Type: research